CA
NZ
UK
AU
IND
US
Nayax Ltd. filed a Form 6-K with the U.S. Securities and Exchange Commission on November 12, 2026, reporting that it had submitted a shelf prospectus to the Israel Securities Authority on the same date.
Riskified Ltd. filed a Form 6-K with the SEC on November 12, 2026, reporting the resignation of board director Tanzeen Syed and announcing financial results for the three and nine months ended September 30, 2026.
Genius Group Limited filed a Form 6-K on November 12, 2026, disclosing that NYSE Regulation halted trading in its ordinary shares on November 10, 2026, and that the company is proceeding with a 1-for-10 share consolidation expected to take effect on November 20, 2026.
Taiwan Semiconductor Manufacturing Company Limited filed a Form 6-K on November 12, 2026, disclosing that current and former employee personal data was made available on an external website without authorization.
Iron Horse Acquisition II Corp. filed a current report on November 12, 2026, disclosing that it and merger target Electra Vehicles, Inc. issued a joint press release announcing Electra's role as the Official Battery Intelligence Partner of Westbrook Racing by Visit Angola at the …
PTL Limited filed a Form 6-K on November 12, 2026, disclosing that its board of directors approved a change in the trading symbol of its Class A ordinary shares on the Nasdaq Capital Market from "PTLE" to "ZYN," effective at the open of trading …
Chicago Atlantic BDC, Inc. filed a Current Report on Form 8-K on November 12, 2026, announcing its financial results for the third quarter ended September 30, 2026, and disclosing details of a pending merger with Chicago Atlantic Real Estate Finance, Inc.
Inflection Point Acquisition Corp. VII filed a Form 8-K on November 12, 2026, reporting that on November 11, 2026, it entered into the Second Amendment to the Business Combination Agreement with Merger Sub and Elroy Air, Inc., modifying stock exchange procedures and lock-up agreement …
Axalta Coating Systems Ltd. filed a Form 425 on November 11, 2026, disclosing that the UK Competition and Markets Authority has completed a Phase 1 review of the proposed merger with Akzo Nobel N.V. and identified competition concerns in the supply of vehicle refinish …
Addex is a Geneva-based, clinical-stage biopharmaceutical company developing small molecule allosteric modulators for neurological disorders. Its lead candidate, dipraglurant, is being evaluated for future development in brain injury recovery, and it has GABAB programs aimed at substance use disorders and chronic cough.
Please wait processing your request...